Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Assembly Biosciences (ASMB) Return on Invested Capital (2017 - 2025)

Historic Return on Invested Capital for Assembly Biosciences (ASMB) over the last 6 years, with Q3 2025 value amounting to 0.43%.

  • Assembly Biosciences' Return on Invested Capital rose 11200.0% to 0.43% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.43%, marking a year-over-year increase of 11200.0%. This contributed to the annual value of 1.23% for FY2024, which is 1800.0% down from last year.
  • According to the latest figures from Q3 2025, Assembly Biosciences' Return on Invested Capital is 0.43%, which was up 11200.0% from 1.94% recorded in Q2 2025.
  • Assembly Biosciences' 5-year Return on Invested Capital high stood at 0.43% for Q3 2025, and its period low was 2.36% during Q3 2023.
  • Its 3-year average for Return on Invested Capital is 1.6%, with a median of 1.55% in 2024.
  • Data for Assembly Biosciences' Return on Invested Capital shows a peak YoY increase of 11200bps (in 2025) and a maximum YoY decrease of -4200bps (in 2025) over the last 5 years.
  • Over the past 3 years, Assembly Biosciences' Return on Invested Capital (Quarter) stood at 1.54% in 2023, then dropped by 0bps to 1.54% in 2024, then surged by 72bps to 0.43% in 2025.
  • Its Return on Invested Capital was 0.43% in Q3 2025, compared to 1.94% in Q2 2025 and 1.54% in Q4 2024.